top of page

Telefone: +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

CB-Lin 0.25mg Tablet

CB-Lin 0.25mg Tablet

Manufacturer/Marketed By : SERUM INSTITUTE OF INDIA

$1.06 $0.84

CB-Lin 0.25mg Tablet contains Cabergoline, a dopamine receptor agonist primarily used to treat conditions associated with elevated prolactin levels (hyperprolactinemia). Prolactin is a hormone produced by the pituitary gland, and...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

CABERGOLINE

Active Pharmaceutical Ingredient

CB-Lin 0.25mg Tablet

SKU SERUM INSTITUTE OF INDIA
Preço original

US$ 1,06

Preço promocional

US$ 0,84

CB-Lin 0.25mg Tablet contains Cabergoline, a dopamine receptor agonist primarily used to treat conditions associated with elevated prolactin levels (hyperprolactinemia). Prolactin is a hormone produced by the pituitary gland, and excessive levels can lead to menstrual irregularities, infertility, and inappropriate milk production in women, and sexual dysfunction in men. This tablet works by stimulating dopamine receptors in the brain, reducing prolactin production.

Active Pharmaceutical Ingredient

CABERGOLINE

Usos

• Hyperprolactinemia: CB-Lin 0.25mg Tablet is commonly prescribed to reduce elevated prolactin levels. High prolactin can disrupt reproductive functions, causing irregular periods, infertility, and lactation-related issues in women. In men, it can lead to decreased libido and erectile dysfunction. By lowering prolactin levels, this medication helps normalize hormonal balance and restores reproductive health.
• Parkinson’s Disease: It is also effective in managing certain symptoms of Parkinson’s disease. The dopamine-agonist action of the drug compensates for dopamine deficiency in the brain, improving motor control and reducing symptoms such as tremors, stiffness, and slow movement.

Benefícios

CB-Lin 0.25mg Tablet primarily acts by stimulating dopamine receptors in the pituitary gland. Dopamine plays a critical role in regulating prolactin secretion. By activating these receptors, Cabergoline effectively suppresses the overproduction of prolactin, alleviating the symptoms of hyperprolactinemia.

Efeitos colaterais

Contact your doctor if you experience severe or persistent side effects. Regular monitoring and reporting of side effects can help ensure a safe treatment experience.

Efeitos colaterais mais comuns

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Efeitos colaterais comuns

• Common Side Effects: Nausea, vomiting, headache, fatigue, stomach upset, constipation, and dizziness.
• Uncommon Side Effects: Low blood pressure, nasal congestion, mood changes, or vision disturbances.
• Rare Side Effects: Heart valve issues, shortness of breath, or leg cramps.

Como usar

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Conselhos de segurança

• Breast Feeding: This medication is not recommended during breastfeeding as it inhibits milk production.
• Alcohol: Avoid consuming alcohol while on this medication, as it may increase the risk of side effects such as dizziness or drowsiness.
• Liver: CB-Lin 0.25mg Tablet should be used cautiously in patients with liver disease, as dosage adjustments may be required.
• Lungs: CB-Lin 0.25mg Tablet should be used with caution in patients with a history of lung conditions, as it may cause or worsen fibrotic reactions.
• Driving: Exercise caution when driving or operating machinery, as CB-Lin 0.25mg Tablet may cause dizziness or lightheadedness.
• Pregnancy: Use CB-Lin 0.25mg Tablet during pregnancy only if prescribed by your doctor. Inform your healthcare provider if you are planning to conceive.

Isenção de responsabilidade

A Sidmex Inovia se esforça para fornecer informações precisas e confiáveis; no entanto, todo o conteúdo deste site, incluindo descrições e composições de produtos, tem caráter meramente informativo e não deve ser considerado um substituto para aconselhamento, diagnóstico ou tratamento médico profissional.

Recomenda-se aos usuários que consultem um profissional de saúde qualificado antes de tomar qualquer decisão médica. As informações fornecidas não devem ser usadas para autodiagnóstico ou automedicação.

Todos os produtos listados destinam-se estritamente a consultas B2B e em grandes quantidades. A Sidmex Inovia não promove o uso direto pelo consumidor e visa apoiar, e não substituir, a relação entre o profissional de saúde e o paciente.

Os nomes de produtos, marcas comerciais e marcas pertencem aos seus respectivos proprietários, e seu uso não implica qualquer afiliação ou endosso. A Sidmex Inovia não se responsabiliza por quaisquer consequências decorrentes do uso das informações fornecidas neste site.

bottom of page